The earnings call reflected a mixed sentiment with several positive highlights, including revenue growth and clinical study success; however, these were offset by significant lowlights, such as reduced guidance, EPS decrease, rollout challenges for Inspire V, and increased operating expenses.
Company Guidance -
Q3 2025
During the Inspire Medical Systems second quarter 2025 conference call, CEO Tim Herbert provided an updated financial outlook, highlighting a revised full-year revenue guidance of $900 million to $910 million, down from the previous $940 million to $955 million, reflecting a 12% to 13% growth over 2024. This adjustment was attributed to challenges in transitioning customers to the Inspire V system, delays in Medicare billing software updates, and a slower rollout of SleepSync, which affected the commercial adoption of Inspire V. The company's diluted net income per share guidance was also adjusted to $0.40 to $0.50, down from $2.20 to $2.30, due to the revenue guidance change and increased marketing costs. Despite these headwinds, Herbert expressed confidence in the company's recovery strategy, including increased marketing efforts and expansion of its footprint, aiming for an accelerated growth trajectory in 2026.
Revenue Growth
Total revenue for the second quarter was $217.1 million, an 11% increase from the $195.9 million generated in the second quarter of 2024. U.S. revenue increased by 10%, and revenue outside the U.S. increased by 23% year-over-year.
Adjusted EBITDA Increase
Adjusted EBITDA for the quarter totaled $44.1 million, which is a 14% increase compared to $38.7 million in the prior year period.
Medicare Reimbursement Proposal
CMS proposed a positive increase for Medicare reimbursement for the Inspire system, with the national average Medicare hospital reimbursement for CPT code 64568 proposed to increase by 4% and ASC reimbursement by 5%.
Clinical Study Success
Early results from the Singapore clinical study demonstrated a 20% reduction in surgical times, with U.S. centers experiencing a more than 20% increase in patient implants in the first half of 2025.
Inspire Medical Systems (INSP) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
INSP Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 04, 2025
$129.95
$87.91
-32.35%
May 05, 2025
$158.74
$161.88
+1.98%
Feb 10, 2025
$180.99
$183.99
+1.66%
Nov 04, 2024
$192.71
$199.00
+3.26%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Inspire Medical Systems (INSP) report earnings?
Inspire Medical Systems (INSP) is schdueled to report earning on Nov 04, 2025, After Close (Confirmed).
What is Inspire Medical Systems (INSP) earnings time?
Inspire Medical Systems (INSP) earnings time is at Nov 04, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.